Gabriel MALOUF

Publications

• 2018

  • Metabolic Response to BRAF-MEK Combination Therapy in Cecal Neuroendocrine Carcinoma With BRAFV600E Mutation and Refractory Lactic Acidosis

    • Alessio Imperiale
    • Adrien Latge
    • Frédérique Schaff-Wendling
    • Bernard Goichot
    • Jean-Emmanuel Kurtz
    • Gabriel Malouf

    Clinical Nuclear Medicine ; Volume: 43 ; Page: 701-702

    HAL DOI

  • Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny

    • Marion Classe
    • Hui Yao
    • Roger Mouawad
    • Chad Creighton
    • Alice Burgess
    • Frederick Allanic
    • Michel Wassef
    • Xavier Leroy
    • Benjamin Verillaud
    • Geoffrey Mortuaire
    • Franck Bielle
    • Christophe Le Tourneau
    • Jean-Emmanuel Kurtz
    • David Khayat
    • Xiaoping Su
    • Gabriel Malouf

    Cell Reports ; Volume: 25 ; Page: 811-821

    HAL DOI

  • Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders

    • A Boileve
    • M Carlo
    • Philippe Barthelemy
    • S Oudard
    • D Borchiellini
    • M Voss
    • S George
    • C Chevreau
    • J Landman-Parker
    • M Tabone
    • D Chism
    • A Amin
    • M Bilen
    • D Bosse
    • A Coulomb-L'Hermine
    • X Su
    • T Choueiri
    • N Tannir
    • Gabriel Malouf

    Journal for Immunotherapy of Cancer ; Volume: 6

    HAL DOI

• 2017

  • NSD1 Inactivation and SETD2 Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell Carcinomas

    • Xiaoping Su
    • Jianping Zhang
    • Roger Mouawad
    • Eva Compérat
    • Morgan Rouprêt
    • Frederick Allanic
    • Jérôme Parra
    • Marc-Olivier Bitker
    • Erika Thompson
    • Banumathy Gowrishankar
    • Jane Houldsworth
    • John Weinstein
    • Jorg Tost
    • Bradley Broom
    • David Khayat
    • Jean-Philippe Spano
    • Nizar Tannir
    • Gabriel G. Malouf

    Cancer Research ; Volume: 77 ; Page: 4835-4845

    HAL DOI